Phase 2 Chronic Kidney Disease Clinical Trials
32 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 32 trials
Recruiting
Phase 2
Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
Chronic Kidney DiseasesPruritus
Vifor Fresenius Medical Care Renal Pharma18 enrolled12 locationsNCT06593392
Recruiting
Phase 2
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
Chronic Kidney Disease
Boehringer Ingelheim416 enrolled153 locationsNCT06926660
Recruiting
Phase 2
Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis
CKD (Chronic Kidney Disease) Stage 5DESRD
McGill University Health Centre/Research Institute of the McGill University Health Centre30 enrolled1 locationNCT06913647
Recruiting
Phase 2
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Novo Nordisk A/S465 enrolled147 locationsNCT06717698
Recruiting
Phase 2
A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
Chronic Kidney Disease and Hypertension
AstraZeneca218 enrolled70 locationsNCT07222917
Recruiting
Phase 2
Swedish Cardiac And Renal Failure Study-1
Chronic Kidney DiseaseHFrEF - Heart Failure With Reduced Ejection Fraction
Karolinska Institutet40 enrolled1 locationNCT07029503
Recruiting
Phase 1Phase 2
A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)
Chronic Kidney Disease(CKD)
Regeneron Pharmaceuticals56 enrolled10 locationsNCT05092347
Recruiting
Phase 1Phase 2
A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
Healthy VolunteersChronic Kidney Disease
Ingenia Therapeutics INC94 enrolled1 locationNCT07231679
Recruiting
Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
Chronic Kidney DiseasesEnd Stage Kidney Disease (ESRD)Major Depressive Disorder
Stony Brook University201 enrolled4 locationsNCT04422652
Recruiting
Phase 2
UBT251 Injection Phase II Clinical Study (CKD)
Chronic Kidney DiseaseObesity &Amp; Overweight
The United Bio-Technology (Hengqin) Co., Ltd.180 enrolled1 locationNCT07134335
Recruiting
Phase 2
A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria
Chronic Kidney Disease With High Proteinuria
AstraZeneca224 enrolled10 locationsNCT06942910
Recruiting
Phase 2
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
Chronic Kidney Disease
Emory University156 enrolled2 locationsNCT05928936
Recruiting
Phase 2
Acute Equol Supplementation and Vascular Function in Women With and Without CKD
Chronic Kidney DiseasesWomenVascular Function
University of Colorado, Denver38 enrolled1 locationNCT06128278
Recruiting
Phase 2
Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine
Chronic Kidney Diseases
Brigham and Women's Hospital20 enrolled1 locationNCT04500665
Recruiting
Phase 2
Activated Charcoal Use in Chronic Kidney Disease Patients
End Stage Renal Disease (ESRD)CKD 5D, HemodialysisCKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder
Mansoura University40 enrolled1 locationNCT06906874
Recruiting
Phase 1Phase 2
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
Heart FailureChronic Kidney DiseasesKidney Diseases+1 more
Northwestern University60 enrolled1 locationNCT05719714
Recruiting
Phase 2
Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis)
Metabolic Dysfunction-Associated SteatohepatitisChronic Kidney Disease Stage 3Chronic Kidney Disease Stage 2
Enyo Pharma60 enrolled1 locationNCT06939816
Recruiting
Phase 2
Sit Less, Interact and Move More (SLIMM) 2 Study
ObesityChronic Kidney Diseases
Srinvasan Beddhu156 enrolled2 locationsNCT05173714
Recruiting
Phase 2
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
Insulin ResistanceChronic Kidney DiseasesFatigue+4 more
University of California, Davis80 enrolled2 locationsNCT04984226
Recruiting
Phase 2
Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidney Disease Undergoing Maintenance Dialysis
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shaanxi Micot Pharmaceutical Technology Co., Ltd.310 enrolled1 locationNCT06976177